Related Experiment Video
Updated: Aug 1, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Prevalence and Associated Risk Factors of Cerebral Microbleeds in Egyptian Patients with Acute Ischemic Stroke and
Takwa H M Elkhatib1, Ahmed F Elsaid2, Rania M Al-Molla3
1Department of Neurology, Zagazig University; Egypt.
Background:
Few studies addressed the prevalence of cerebral microbleeds (CMB) and associated risk factor profile in Egyptian ischemic cerebral stroke patients with atrial fibrillation (AF).
Methods:
The prevalence of CMB was estimated in 150 cases of AF ischemic stroke patients and compared to the prevalence in 150 age- and sex-matched controls of ischemic stroke patients without AF. CMB-associated risk factors were identified by comparing AF ischemic stroke patients with and without CMB. All participants were subjected to complete general, neurological examination, and magnetic resonance imaging.
Results:
The prevalence of CMBs in ischemic stroke with and without AF was 40.7% and 49.3%, respectively. Age, hypertension, diabetes mellitus, past history of stroke, antiplatelet, anticoagulant, National Institutes of Health Stroke Scale, CHA2DS2VASc, and white matter lesions (WML) were significant risk factors associated with CMB on univariate analysis. On multivariable logistic regression analysis, age (odds ratio [OR] 1.1, confidence interval [CI] 1.02-1.13), hypertension (OR 3.2, CI 1.19-8.81), anticoagulant (OR 3.3, CI 1.17-9.40), and WML (OR 9.6, CI 3.49-26.3) were the only independent risk factors associated with the presence of CMBs.
Conclusions:
AF in ischemic stroke patients was not associated with higher prevalence of CMBs. Old age, hypertension, anticoagulant treatment, and WML were the independent risk factors associated with CMB in AF ischemic stroke patients. Our results suggest that elderly hypertensive AF ischemic stroke patients maintained on anticoagulant therapy should be screened for the incidence of CMBs and monitored regularly for the development of intracerebral hemorrhage.
Insights
Cerebral microbleeds (CMB) prevalence was similar in Egyptian ischemic stroke patients with and without atrial fibrillation (AF). Key risk factors for CMB include older age, hypertension, anticoagulant use, and white matter lesions.
Area of Science:
- Neurology
- Radiology
- Cardiology
Background:
- Cerebral microbleeds (CMB) are increasingly recognized in stroke patients.
- Limited data exists on CMB prevalence and risk factors in Egyptian patients with ischemic stroke and atrial fibrillation (AF).
Purpose of the Study:
- To determine the prevalence of CMB in Egyptian ischemic stroke patients with AF.
- To identify risk factors associated with CMB in this population.
Main Methods:
- A case-control study involving 150 ischemic stroke patients with AF and 150 age/sex-matched controls without AF.
- All participants underwent neurological examination and magnetic resonance imaging (MRI).
- Risk factors for CMB were analyzed using univariate and multivariable logistic regression.
Main Results:
- CMB prevalence was 40.7% in ischemic stroke patients with AF and 49.3% in those without AF.
- Univariate analysis identified age, hypertension, diabetes, prior stroke, antiplatelet/anticoagulant use, NIHSS, CHA2DS2-VASc score, and WML as risk factors.
- Independent risk factors for CMB were older age (OR 1.1), hypertension (OR 3.2), anticoagulant use (OR 3.3), and white matter lesions (WML) (OR 9.6).
Conclusions:
- Atrial fibrillation (AF) was not associated with a higher prevalence of CMB in ischemic stroke patients.
- Older age, hypertension, anticoagulant therapy, and WML are independent risk factors for CMB.
- Elderly hypertensive AF stroke patients on anticoagulants require screening for CMB and monitoring for intracerebral hemorrhage.
More Related Videos
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

